Skip to content

Antenatal Body Shape Index and Pregnancy Complications

Relationship Between Antenatal Body Shape Index and Pregnancy Complications

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07022158
Enrollment
170
Registered
2025-06-15
Start date
2023-09-01
Completion date
2024-04-01
Last updated
2025-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Mass Index, Gestational Complications, Gestational Diabetes Mellitus (GDM), Gestational Hypertension, Preeclampsia (PE), Waist Circumference

Keywords

gestational hypertension, gestational diabetes, preeclampsia, body shape index, waist circumference

Brief summary

Background/aim: Gestational diabetes (GDM), gestational hypertension (GHT) and preeclampsia are common complications of pregnancy. In this study, it was aimed to determine the relationship between body shape index (ABSI), calculated based on antenatal measurements of the height, weight and waist circumference, and GDM, GHT and preeclampsia. Materials and methods: 170 patients at 6-16th weeks of gestation were prospectively analyzed. Body mass index (BMI) and ABSI were calculated. Patients were analyzed according to the presence of GDM, GHT and preeclampsia at follow-up. Our study is the first in terms of its subject and makes a significant contribution to the literature.

Interventions

OTHERThe patients participating in the study were between 6 and 16 weeks of pregnancy. Height, body weight, and waist circumference were measured at the first antenatal visit at 2 weeks.

170 patients at 6-16th weeks of gestation were prospectively analyzed. Body mass index (BMI) and ABSI were calculated. Patients were analyzed according to the presence of GDM, GHT and preeclampsia at follow-up.

Sponsors

Abant Izzet Baysal University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years
Healthy volunteers
Yes

Inclusion criteria

* Having a singleton pregnancy * Pregnancy follow-up and birth must have taken place at Bolu Abant İzzet Baysal University Training and Research Hospital. * Voluntary informed consent form must be signed to participate in the study.

Exclusion criteria

* Multiple pregnancies * Additional systemic and chronic diseases (chronic hypertension, DM, hepatic diseases such as cholestasis, cardiac diseases, rheumatic diseases, renal diseases…) * History of Gestational Diabetes, Gestational Hypertension and Preeclampsia in previous pregnancies

Design outcomes

Primary

MeasureTime frameDescription
Calculation of body shape index at 6-16 weeks of gestation6-16 weeks of gestationThe study included pregnant women who applied to the Obstetrics and Gynecology outpatient clinic of Bolu Abant İzzet Baysal Training and Research Hospital between September 2023 and March 2024. During the first antenatal examination of the patients at 6-16 weeks of pregnancy, body shape indexes were calculated by measuring height, body weight and waist circumference.

Secondary

MeasureTime frameDescription
Number of patients developing pregnancy complicationsgestation period and first 6 weeks postpartumPatients whose body shape index was calculated at 6-16 weeks of gestation were evaluated during pregnancy follow-up according to the development of Gestational Diabetes, Gestational Hypertension and Preeclampsia.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026